ArticleJournal of psychiatric research2026
Examining the predictive value of anxiety, depression, and suicidal ideation screening in determining psychosis risk.
Article in Journal of psychiatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Psychosis is a medical and psychological term referring to an array of symptoms including perceptual disturbances, delusional beliefs, and disorganized behavior. Timely identification of psychotic disorders helps individuals be connected to early intervention or first-episode psychosis treatment programs which improve clinical and functional outcomes. Anxiety and depression are common comorbidities and may be precursors to psychotic disorders. Although screening for mental health within the primary care setting has increased in recent years, questions remain about who and when to screen for psychosis. Within a larger project exploring the feasibility of screening for psychosis in primary care, this project examines the relationship between three mental health screeners: the Prodromal Questionnaire-16 (PQ-16; used to identify individuals with psychosis symptoms), the Generalized Anxiety Disorder-7 (GAD-7; screens for anxiety), and the Patient Health Questionnaire-9 (PHQ-9; screens for depression with one question measuring suicide ideation). The current study examined the relationship between these three screeners in a sample of adolescent and young adult patients (N = 180) from four primarily pediatric practices in Maine. Patients completed all three screeners and were triaged by trained behavioral health clinicians into five clinical groups, which were collapsed into two groups: no psychosis concern or psychosis concern. Results demonstrated that depressive symptoms and suicidal ideation most consistently predicted psychosis risk, considering both self-report and psychosis-risk triage. These findings suggest prioritizing psychosis risk screening if young patients screen positive for depression and/or suicidal ideation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.